Edition:
United States

Eaton Corporation PLC (ETN)

ETN on New York Consolidated

67.32USD
26 Aug 2016
Change (% chg)

$-0.07 (-0.10%)
Prev Close
$67.39
Open
$67.67
Day's High
$68.20
Day's Low
$67.06
Volume
1,509,493
Avg. Vol
2,313,623
52-wk High
$68.20
52-wk Low
$46.19

ETN

Chart for ETN

About

Eaton Corporation plc is a power management company. The Company provides energy-efficient solutions that help its customers to manage electrical, hydraulic and mechanical power. It operates in four segments: Electrical Products and Electrical Systems and Services, Hydraulics, Aerospace and Vehicle. The Electrical Products... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $30,610.40
Shares Outstanding(Mil.): 454.70
Dividend: 0.57
Yield (%): 3.39

Financials

  ETN Industry Sector
P/E (TTM): 16.60 20.66 21.49
EPS (TTM): 4.06 -- --
ROI: 6.97 10.80 5.75
ROE: 12.06 12.49 8.43

BRIEF-Eaton Q2 operating earnings per share $1.07

* Eaton reports second quarter net income and operating earnings per share of $1.07, above midpoint of guidance

Aug 02 2016

BRIEF-Eaton Corporation says board expanded its size to fourteen members

* Says board expanded its size to fourteen members and elected Dorothy C. Thompson to fill the vacancy - sec filing Source - http://bit.ly/2aBOeuy Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)

Jul 29 2016

World champions Barber and Drouin lead Canadian team

World champions Shawn Barber and Derek Drouin and heptathlon favorite Brianne Theisen-Eaton headline a 65-member Canadian athletics team for the Rio Olympics announced on Monday.

Jul 11 2016

Athletics-World champions Barber and Drouin lead Canadian team

July 11 World champions Shawn Barber and Derek Drouin and heptathlon favourite Brianne Theisen-Eaton headline a 65-member Canadian athletics team for the Rio Olympics announced on Monday.

Jul 11 2016

BRIEF-Catalyst Pharma finalizes late-stage trial design with FDA for Firdapse

* Catalyst Pharmaceuticals announces agreement with FDA on confirmatory phase 3 study protocol for Firdapse in Lambert-Eaton Myasthenic Syndrome

Jun 13 2016

BRIEF-Eaton Corporation Plc says Q1 operating EPS $0.88

* Q1 earnings per share view $0.85 -- Thomson Reuters I/B/E/S

Apr 29 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : S&P Capital IQ – STARS Reports
$127.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.